NCT00262548
- Conditions
- Body Weight, Diabetes Mellitus, Diabetes Mellitus, Type 2, +10 more
- Locations
-
- Research site Cuernavaca, Morelos, Mexico
Clinical trial condition
Diabetes Mellitus, Type 2
Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.
7,968 public trials
717 recruiting studies
Diabetes Mellitus, Type 2 trial results
NCT00520962
- Conditions
- Cardiovascular Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 2, +9 more
- Locations
-
- Medicine Division, Diabetology, Endocrinology and Metabolic Disease Unit, IRCCS San Raffaele Milan, Italy
NCT00110851
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- Phoenix Internal Medicine Associates Waterbury, Connecticut, United States
- University Clinical Research-DeLand DeLand, Florida, United States
- Center for Diabetes and Endocrine Care Hollywood, Florida, United States
- Genesis Research International Longwood, Florida, United States
NCT00110864
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- Phoenix Internal Medicine Associates Waterbury, Connecticut, United States
- Center for Diabetes and Endocrine Care Hollywood, Florida, United States
- Genesis Research International Longwood, Florida, United States
- Baptist Diabetes Associates Miami, Florida, United States
NCT00341614
- Conditions
- Behavior, Cardiovascular Diseases, Diabetes Mellitus, +6 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
NCT00220207
- Conditions
- Adherence Interventions, Behavior, Diabetes Mellitus, +11 more
- Locations
-
- Harborview Medical Center Seattle, Washington, United States
NCT00486941
- Conditions
- Behavior, Body Weight, Cardiovascular Diseases, +19 more
- Locations
-
- Björknäs Health Centre Boden, Sweden
NCT00368134
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Novartis Pharmaceuticals Tokyo, Japan
Completed
Complaints Associated With Use of Pre-Filled Pen B With Type 2 Diabetics on Twice-Daily Insulin
NCT00231725
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Memphis, Tennessee, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pamplona, Spain
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Requena, Spain
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Middlesbrough, United Kingdom
NCT00006432
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Duke University Medical Center Durham, North Carolina, United States